by nikki mann | Jun 20, 2024 | News
We were delighted to welcome Flagship Pioneering to the Milner Therapeutics Institute this week. Noubar Afeyan and colleagues from Flagship visited the Institute to learn more about the Milner model and discuss how we might work together in future. It was fantastic to...
by nikki mann | Jun 15, 2024 | News
We are delighted to share that our Director, Professor Sir Tony Kouzarides – a Professor of Cancer Biology at the University of Cambridge and a Senior Group Leader at the Gurdon Institute – has been awarded a knighthood for his services to healthcare innovation and...
by nikki mann | Jun 10, 2024 | News
Work at the Milner Therapeutics Institute in collaboration with Professor Matthias Zilbauer has made a promising step toward identifying more precise and personalised treatments for patients with Crohn’s disease. The research published today in Gut reports how Milner...
by nikki mann | May 20, 2024 | News
We are delighted to announce that Chun Hao Wong has joined the Milner team as the MTI lead for the new MRC-AstraZeneca-University of Cambridge Functional Genomics Screening Laboratory (FGSL). The FGSL aims to combine know-how and experience to accelerate the...
by nikki mann | Apr 18, 2024 | News
This year the Milner Institute was delighted to take part in the University of Cambridge’s interdisciplinary Cambridge Festival. The Festival takes place each Spring and includes a mixture of online, on-demand and in-person events covering all aspects of the...
by nikki mann | Mar 26, 2024 | News
The functional genomics screening laboratory (FGSL), a joint venture between our Institute at the University of Cambridge, the Medical Research Council (MRC) and AstraZeneca, has opened a call for project proposals. The call, which opened on 26th March, is relevant to...
